DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants.

Information source: Wyeth
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Vaccines, Pneumococcal

Intervention: 13-valent Pneumococcal Conjugate Vaccine (Biological); 7 valent pneumococcal conjugate vaccine (Biological)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth
Trial Manager, Principal Investigator, Affiliation: For Spain, infomed@wyeth.com

Summary

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomitantly with routine pediatric vaccinations in Spain.

Clinical Details

Official title: A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Spain

Study design: Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Safety Study

Primary outcome: To compare immunogenicity of 13vPnC to Prevenar using serotype specific serum IgG antibody levels; to evaluate immunogenicity of antigens in concomitant vaccines; to assess safety by local injection site reactions and systemic events, and adverse events.

Eligibility

Minimum age: 42 Days. Maximum age: 98 Days. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Healthy 2-month-old infants

- Available for the entire study period

Exclusion criteria:

- Previous vaccination with any vaccine before the start of the study

- Known contraindication to vaccination

Locations and Contacts

A Coruna 15006, Spain

Almeria 04007, Spain

Almeria 04009, Spain

Almeria 04120, Spain

Barcelona 08017, Spain

Barcelona 08025, Spain

La Coruna 15270, Spain

Madrid 28041, Spain

Madrid 28021, Spain

Madrid 28041, Spain

Malaga 29015, Spain

Ourense 32005, Spain

Sevilla 41013, Spain

Valencia 46024, Spain

Valencia 46013, Spain

Valencia 46200, Spain

Valencia 46021, Spain

Valencia 46011, Spain

Valencia 46023, Spain

Valencia 46022, Spain

Valencia 46008, Spain

Santiago de Compostela, A Coruna 15706, Spain

Ferrol, A Coruna 15405, Spain

Sabadell, Barcelona 08208, Spain

Argentona, Barcelona 08310, Spain

Sant Cugat del Valles, Barcelona 08195, Spain

Sant Cugat del Valles, Barcelona 08197, Spain

Sant Adria de Besos, Barcelona 08930, Spain

Bilbao, Bizkaia 48013, Spain

Burela, Lugo 27880, Spain

Alcorcon, Madrid 28922, Spain

Getafe, Madrid 28900, Spain

Fuenlabrada, Madrid 28943, Spain

Mostoles, Madrid 28937, Spain

Getafe, Madrid 28902, Spain

Parla, Madrid 28980, Spain

Antequera, Malaga 29200, Spain

Pamplona, Navarra 31008, Spain

Vigo, Pontevedra 36204, Spain

La Eliana, Valencia 46183, Spain

Burjassot, Valencia 46110, Spain

Quart de Poblet, Valencia 46930, Spain

Additional Information

Starting date: October 2006
Ending date: July 2008
Last updated: December 21, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012